U.S. Markets open in 7 hrs 43 mins
  • S&P Futures

    4,533.25
    -42.50 (-0.93%)
     
  • Dow Futures

    34,559.00
    -63.00 (-0.18%)
     
  • Nasdaq Futures

    15,687.50
    -301.00 (-1.88%)
     
  • Russell 2000 Futures

    2,156.20
    -49.00 (-2.22%)
     
  • Crude Oil

    66.22
    -0.28 (-0.42%)
     
  • Gold

    1,782.10
    +21.40 (+1.22%)
     
  • Silver

    22.57
    +0.25 (+1.12%)
     
  • EUR/USD

    1.1317
    +0.0012 (+0.1019%)
     
  • 10-Yr Bond

    1.3430
    -0.1050 (-7.25%)
     
  • Vix

    30.67
    +2.72 (+9.73%)
     
  • GBP/USD

    1.3235
    -0.0067 (-0.5029%)
     
  • USD/JPY

    112.8000
    -0.4090 (-0.3613%)
     
  • BTC-USD

    48,579.08
    -912.32 (-1.84%)
     
  • CMC Crypto 200

    1,367.14
    -74.62 (-5.18%)
     
  • FTSE 100

    7,122.32
    -6.89 (-0.10%)
     
  • Nikkei 225

    28,029.57
    +276.20 (+1.00%)
     

18 Stocks Moving in Friday's Pre-Market Session

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Gainers

  • eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) rose 25.5% to $14.41 in pre-market trading after the company, in collaboration with investigators at Baylor College of Medicine, announced the presentation of new data for zotatifin in animal models of triple-negative breast cancer at the 2021 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.

  • Camber Energy, Inc.. (NYSE: CEI) rose 19.7% to $2.13 in pre-market trading after jumping around 96% on Thursday.

  • Immuron Limited (NASDAQ: IMRN) rose 14.8% to $4.04 in pre-market trading. Immuron announced in a publication from the Hebrew University Hadassah Medical Center 'Augmented Antiviral T Cell Immunity by Oral Administration of Imm-124e in Preclinical Models and a Phase I/iia Clinical Trial: a Method for the Prevention and Treatment of Covid-19.'

  • Sundial Growers Inc. (NASDAQ: SNDL) rose 14.3% to $0.7407 in pre-market trading after the company announced plans to acquire Alcanna for total consideration of approximately $346 million.

  • Momentive Global Inc. (NASDAQ: MNTV) rose 10.9% to $23.98 in pre-market trading. Momentive Global is weighing options, including a potential sale after receiving takeover interest, Bloomberg reported.

  • Vaxart, Inc. (NASDAQ: VXRT) rose 9.7% to $7.78 in pre-market trading after the company reported a Duke University-led study published in bioRxiv showed that the company's investigational oral tablet vaccine reduced the airborne transmission of SARS-CoV-2 virus in an animal model.

  • InflaRx N.V. (NASDAQ: IFRX) rose 9.7% to $2.60 in pre-market trading.

  • Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) shares rose 9.6% to $1.71 in pre-market trading.

  • Soligenix, Inc. (NASDAQ: SNGX) shares rose 7.1% to $1.06 in pre-market trading after gaining 5% on Thursday.

  • DatChat, Inc. (NASDAQ: DATS) shares rose 6.6% to $8.57 in pre-market trading after gaining over 9% on Thursday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Macquarie Infrastructure Corporation (NYSE: MIC) shares fell 91.1% to $3.58 in pre-market trading.

  • Allogene Therapeutics, Inc. (NASDAQ: ALLO) shares fell 38.1% to $15.09 in pre-market trading after the company reported the FDA placed a hold on the company's AlloCAR T clinical trials.

  • Cellectis S.A. (NASDAQ: CLLS) fell 21.4% to $9.44 in pre-market trading.

  • Agile Therapeutics, Inc. (NASDAQ: AGRX) shares fell 19.8% to $0.7551 in pre-market trading after the company announced an offering of common stock and warrants.

  • Cidara Therapeutics, Inc. (NASDAQ: CDTX) fell 19.8% to $1.50 in pre-market trading after the company reported commencement of concurrent common and preferred stock offering.

  • MaxCyte, Inc. (NASDAQ: MXCT) fell 12.2% to $9.40 in pre-market trading.

  • Rocket Lab USA, Inc. (NASDAQ: RKLB) shares fell 8.2% to $14.20 in pre-market trading after gaining over 10% on Thursday.

  • Huaneng Power International, Inc. (NYSE: HNP) fell 6.2% to $19.53 in pre-market trading.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.